Data / Form D filings / OneSkin, Inc.
OneSkin, Inc.: Form D filings
OneSkin, Inc., a biotechnology company in San Francisco, CA, filed 4 Form D notices with the SEC between 2017 and 2025. The latest, on June 12, 2025, reports $20.4 million sold of a $20.4 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 953 INDIANA STREET, San Francisco, CA, 94107
- Phone
- (415) 910-8517
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1703427
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 12, 2025 | New notice | $20,359,280 | $20,359,280 | 1 | May 29, 2025 | sec.gov | |
| Oct 3, 2024 | New notice | $6,999,929 | $6,999,929 | 11 | Sep 23, 2024 | sec.gov | |
| Oct 27, 2022 | New notice | $12,412,714 | $12,412,714 | 19 | Oct 14, 2022 | sec.gov | |
| Apr 26, 2017 | New notice | $2,376,594 | $626,594 | $1,750,000 | 3 | Apr 1, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Carolina Reis de Oliveira | Executive Officer, Director | |
| Alessandra Zonari | Director | |
| Tara Poseley | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jun 9, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what OneSkin, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.